Preference-weighted health status associated with substance use-disorders treatment

Journal of Studies on Alcohol

Volumn 67, Issue 3, 2006, Pages 436-444

  Pyne, Jeffrey M ^a,b   Booth, Brenda M ^a,c   Farahati, Farah ^a,d   Tripathi, Shanti ^a,c   Smith, G Richard ^a,c   Marques, Paul R ^a,e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Canadian Coordinating Office for Health Technology Assessment   (Canada)

^e PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; REMISSION; RESPONSIBILITY; SHORT FORM 36; SUBSTANCE ABUSE; TASTE PREFERENCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WELLBEING;

EID: 33646013887     PISSN: 0096882X     EISSN: None     Source Type: Journal    
DOI: 10.15288/jsa.2006.67.436     Document Type: Article

References (57)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Washington, DC, 1994.
2. ANDERSON, J.P., BUSH, J.W., CHEN, M., AND DOLENC, D. Policy space areas and properties of benefit-cost/utility analysis. JAMA 255: 794-795, 1986.
3. BABOR, T.F., BROWN, J., AND DEL BOCA, F.K. Validity of self-reports in applied research on addictive behaviors: Factor or fiction? Behav. Assess. 12: 5-31, 1990.
4. BARNETT, P.G. AND HUI, S.S. The cost-effectiveness of methadone maintenance. Mt Sinai J. Med. 67: 365-374, 2000.
5. BARNETT, P.G., ZARIC, G.S., AND BRANDEAU, M.L. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 96: 1267-1278, 2001.
6. BLEICHRODT, H. AND JOHANNESSON, M. Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. J. Hlth Econ. 16: 155-175, 1997.
7. BOMBARDIER, C., WARE, J., RUSSELL, I.J., LARSON, M., CHALMERS, A., AND READ, J.L. Auranofin therapy and quality of life in patients with rheumatoid arthritis: Results of a multicenter trial. Amer. J. Med. 81: 565-578, 1986.
8. BOYD, N.F., SUTHERLAND, H.J., HEASMAN, K.Z., TRICHLER, D.L., AND CUMMINOS, B.J. Whose utilities for decision analysis? Med. Dec. Making 10: 58-67, 1990.
9. BRAZIER, J., ROBERTS, J., AND DEVERILL, M. The estimation of a preference-based measure of health from the SF-36. J. Hlth Econ. 21: 271-292, 2002.
10. BRAZIER, J., USHERWOOD, T., HARPER, R., AND THOMAS, K. Deriving a preference-based single index from the UK SF-36 Health Survey. J. Clin. Epidemiol. 51: 1115-1128, 1998.
11. BURY-MAYNARD, D. Developing a utility index for substance abuse: Theory and application. Waltham, MA: Florence Heller Graduate School for Advance Studies in Social Welfare, Brandeis University, 1999.
12. CARTWRIGHT, W.S. Costs of drug abuse to society. J. Ment. Hlth Policy Econ. 2: 133-134, 1999.
13. CARTWRIGHT, W.S. Cost-benefit analysis of drug treatment services: Review of the literature. J. Ment. Hlth Policy Econ. 3: 11-26, 2000.
14. CISLER, R.A. AND ZWEBEN, A. Development of a composite measure for assessing alcohol treatment outcome: Operationalization and validation. Alcsm Clin. Exp. Res. 23: 263-271, 1999.
15. CROMWELL, J., BARTOSCH, W.J., FIORE, M.C., HASSELBLAD, V., AND BAKER, T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 278: 1759-1766, 1997.
16. DIEHR, P., PSATY, B.M., AND PATRICK, D.L. Effect size and power for clinical trials that measure years of healthy life. Stat. Med. 16: 1211-1223, 1997.
17. EUROQOL GROUP. EuroQol: A new facility for the measurement of health-related quality of life. Hlth Policy 16: 199-208, 1990.
18. FARAHATI, F., MARCOTTE, D.E., AND WILCOX-GOK, V. The effects of parent's psychiatric disorders on children's high school dropout. Econ. Educ. Rev. 22: 167-178, 2003.
19. FLETCHER, B.W. AND BATTJES, R.J. Introduction to the special issue: Treatment process in DATOS. Drug Alcohol Depend. 57: 81-87, 1999.
20. FOSTER, J.H., PETERS, T.J., AND MARSHALL, E.J. Quality of life measures and outcome in alcohol-dependent men and women. Alcohol 22: 45-52, 2000.
21. FRENCH, M.T. Economic evaluation of alcohol treatment services. In: GALANTER, M. (Ed.) Recent Developments in Alcoholism, Vol. 15: Services Research in the Era of Managed Care, New York: Kluwer Academic, 2001, pp. 209-228.
22. FRENCH, M.T., SALOME, H.J., KRUPSKI, A., MCKAY, J.R., DONOVAN, D.M., MCLELLAN, A.T., AND DURELL, J. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington. Eval. Rev. 24: 609-634, 2000.
23. FRENCH, M.T. AND ZARKIN, G.A. Effects of drug abuse treatment on legal and illegal earnings. Contemp. Policy Issues 10: 98-110, 1992.
24. GANIATS, T.G., BROWNER, D.K., AND KAPLAN, R.M. Comparison of two methods of calculating Quality-Adjusted Life Years. Qual. Life Res. 5: 162-164, 1996.
25. GODFREY, C. AND PARROTT, S. How can policy makers use available evidence on the cost benefits of drug treatment? J. Ment. Hlth Policy Econ. 3: 55, 2000.
26. GOLD, M.R., SIEGEL, J.E., RUSSELL, L.B., AND WEINSTEIN, M.C. (Eds.) Cost-Effectiveness in Health and Medicine, New York: Oxford Univ. Press, 1996.
27. HADORN, D.C. The problem of discrimination in health care priority setting. JAMA 268: 1454-1459, 1992.
28. HAWTHORNE, G., RICHARDSON, J., AND OSBORNE, R. The Assessment of Quality of Life (AQoL) instrument: A psychometric measure of health-related quality of life. Qual. Life Res. 8: 209-224, 1999.
29. HAYS, R.D., SHERBOURNE, C.D., AND MAZEL, R.M. The Rand 36-Item Health Survey 1.0. Hlth Econ. 2: 217-227, 1993.
30. HOLDER, H.D. Alcoholism treatment and potential health care cost saving. Med. Care 25: 52-71, 1987.
31. HOLDER, H.D. Cost benefits of substance abuse treatment: An overview of results from alcohol and drug abuse. J. Ment. Hlth Policy Econ. 1: 23-29, 1998.
32. HOLDER, H.D. AND BLOSE, J.O. The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. J. Stud. Alcohol 53: 293-302, 1992.
33. HOLLINGWORTH, W., DEYO, R.A., SULLIVAN, S.D., EMERSON, S.S., GRAY, D.T., AND JARVIK, J.G. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Hlth Econ. 11: 71-85, 2002.
34. KAIROUZ, S. AND DUBE, L. Abstinence and well-being among members of Alcoholics Anonymous: Personal experience and social perceptions. J. Social Psychol. 140: 565-579, 2000.
35. KAPLAN, R.M., BUSH, J.W., AND BERRY, C.C. Health status: Types of validity and the index of well-being. Hlth Serv. Res. 11: 478-507, 1976.
36. KAPLAN, R.M., GANIATS, T.G., ROSEN, P., SIEBER, W., AND ANDERSON, J. Development of a self-administered Quality of Well-Being scale (QWBSA): Initial studies. Qual. Life Res. 4: 443-444, 1995.
37. KRAEMER, K.L., MAISTO, S.A., CONIGLIARO, J., MCNEIL, M., GORDON, A.J., AND KELLEY, M.E. Decreased alcohol consumption in outpatient drinkers is associated with improved quality of life and fewer alcohol-related consequences. J. Gen. Intern. Med. 17: 382-386, 2002.
38. LAUPACIS, A., FEENY, D., DETSKY, A.S., AND TUGWELL, P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can. Med. Assoc. J. 146: 473-481, 1992.
39. MCCOLLISTER, K.E. AND FRENCH, M.T. The relative contribution of outcome domains in the total economic benefit of addiction interventions: A review of first findings. Addiction 98: 1647-1659, 2003.
40. MCLELLAN, A.T., ALTERMAN, A.I., METZCER, D.S., GRISSOM, G.R., WOODY, G.E., LUBORSKY, L., AND O'BRIEN, C.P. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. J. Con. Clin. Psychol. 62: 1141-1158, 1994.
41. MILLER, T.R., GALBRAITH, M.S., AND LAWRENCE, B.A. Costs and benefits of a community sobriety checkpoint program. J. Stud. Alcohol 59: 462-468, 1998.
42. MULLAHY, J. AND SINDELAR, J. Life-cycle effects of alcoholism on education, earnings, and occupation. Inquiry 26: 272-282, 1989.
43. PATRICK, D.L., SITTAMPALAM, Y., SOMERVILLE, S.M., CARTER, W.B., AND BERGNER, M. A cross-cultural comparison of health status values. Amer. J. Publ. Hlth 75: 1402-1407, 1985.
44. PYNE, J.M., ROST, K.M., FARAHATI, F., TRIPATHI, S.P., SMITH, J., WILLIAMS, D.K., FORTNEY, J., AND COYNE, J.C. One size fits some: The impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention. Psychol. Med. 35: 839-854, 2005.
45. PYNE, J.M., ROST, K.M., ZHANG, M., WILLIAMS, D.K., SMITH, J., AND FORTNEY, J. Cost-effectiveness of a primary care depression intervention. J. Gen. Intern. Med. 18: 432-441, 2003.
46. RICE, D.P., KELMAN, S., AND MILLER, L.S. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988. Pub. Hlth Rep. 106: 280-292, 1991.
47. ROMEIS, J.C., WATERMAN, B., SCHERRER, J.F., GOLDBERG, J., EISEN, S.A., HEATH, A.C., BUCHOLZ, K.K., SLUTSKE, W.S., LYONS, M.J., TSUANG, M.T., AND TRUE, W.R. The impact of sociodemographics, comorbidity and symptom recency on health-related quality of life in alcoholics. J. Stud. Alcohol 60: 653-662, 1999.
48. SCHOENBAUM, M., UNUTZER, J., SHERBOURNE, C., DUAN, N., RUBENSTEIN, L.V., MIRANDA, J., MEREDITH, L.S., CARNEY, M.F., AND WELLS, K. Cost-effectiveness of practice-initiated quality improvement for depression: Results of a randomized controlled trial. JAMA 286: 1325-1330, 2001.
49. SIMON, G.E., KATON, W.J., VONKORFF, M., UNUTZER, J., LIN, E.H., WALKER, E.A., BUSH, T., RUTTER, C., AND LUDMAN, E. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Amer. J. Psychiat. 158: 1638-1644, 2001a.
50. SIMON, G.E., MANNING, W.G., KATZELNICK, D.J., PEARSON, S.D., HENK, H.J., AND HELSTAD, C.S. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch. Gen. Psychiat. 58: 181-187, 2001b.
51. SMITH, G.R., BURNAM, M.A., MOSLEY, C.L., HOLLENBERG, J.A., MANCINO, M., AND GRIMES, W. Measuring substance abuse treatment and outcomes: The reliability and validity of the substance abuse outcomes module, submitted for publication.
52. SMITH, G.R., JR., FISCHER, E.P., NORDQUIST, C.R., MOSLEY, C.L., AND LEDBETTER, N.S. Implementing outcomes management systems in mental health settings. Psychiat. Serv. 48: 364-368, 1997.
53. SMITH, G.R., ROSS, R.L., AND ROST, K.M. Psychiatric outcomes module: Substance abuse outcomes module (SAOM). In: SEDERER, L.I. AND DICKEY, B. (Eds.) Outcomes Assessment in Clinical Practice, Baltimore, MD: Williams & Wilkins, 1995.
54. SOBELL, L.C., MAISTO, S.A., SOBELL, M.B., AND COOPER, A.M. Reliability of alcohol abusers' self-reports of drinking behavior. Behav. Res. Ther. 17: 157-160, 1979.
55. TORRANCE, G.W., FURLONG, W., FEENY, D., AND BOYLE, M. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 7: 503-520, 1995.
56. VOLK, R.J., CANTOR, S.B., STEINBAUER, J.R., AND CASS, A.R. Alcohol use disorders, consumption patterns, and health-related quality of life of primary care patients. Alcsm Clin. Exp. Res. 21: 899-905, 1997.
57. WARE, J.E., JR., AND SHERBOURNE, C.D. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med. Care 30: 473-483, 1992.